文献速递白血病

优化儿童急性髓系白血病的心血管管理以改善癌症相关结局

Optimizing Cardiovascular Care in Children With Acute Myeloid Leukemia to Improve Cancer-Related Outcomes.
PubMed 文献 · J Clin Oncol · 2018-11-13

本文以一例14岁非裔美国女性急性髓系白血病(AML;FAB M2,t[8;21][q22;q22.1])患者为例,描述其在常规化疗和强化治疗期间出现感染性休克及蒽环类药物相关心脏毒性(左室射血分数从60%降至28%),并综述相关文献及作者建议的管理方法。

要点

  • 基线 echocardiogram 示左室收缩功能正常(EF 60%;SF 32%),强化治疗1前未复查。
  • 强化治疗1期间发生草绿色链球菌脓毒症,恢复后复查EF 53%、SF 27%,仍开始强化治疗2。
  • 强化治疗2第3天出现心力衰竭表现,复查EF 28%、SF 14%,当日米托蒽醌被省略并请心脏科会诊。

核心结论

  • 本文通过病例展示儿童AML治疗过程中心血管并发症的识别与管理挑战,并总结作者建议的管理方法。

研究设计与样本

  • 肿瘤学大查房系列文章:先呈现病例,随后描述诊断与管理挑战、复习相关文献并总结作者建议的管理方法。

主要发现

  • 14岁非裔美国女性因乏力、易瘀伤和发热就诊,查体见散在瘀斑、淋巴结肿大和肝脾肿大,实验室检查示全血细胞减少伴外周原始细胞,骨髓活检诊断为AML(FAB M2,t[8;21][q22;q22.1])。
  • 基线超声心动图示左室收缩功能正常(EF 60%;SF 32%),随后开始常规化疗:两个疗程缓解诱导(阿糖胞苷、依托泊苷和柔红霉素50 mg/m2×3天/疗程),之后强化治疗1(大剂量阿糖胞苷和依托泊苷)、强化治疗2(大剂量阿糖胞苷和米托蒽醌12 mg/m2/剂每日;共四剂)和强化治疗3(大剂量阿糖胞苷和左旋天冬酰胺酶)。
  • 强化治疗1前未复查超声心动图;强化治疗1期间发生草绿色链球菌脓毒症,需在重症监护室4天并接受抗菌药物和正性肌力药物支持。
  • 脓毒症恢复后复查超声心动图示左室收缩功能低正常(EF 53%;SF 27%),随后开始强化治疗2;强化治疗2第3天出现无发热的呼吸急促、心动过速和氧需求增加,胸片示心脏增大和肺血管充血,心脏肌钙蛋白正常,而N末端B型利钠肽原为正常上限的10倍。
  • 复查超声心动图示左室增大伴中重度左室功能减低(EF 28%;SF 14%),第4天米托蒽醌被省略并请心脏科会诊。

局限性

  • 原文未报告局限性

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

The Oncology Grand Rounds series is designed to place original reports published in the Journal into clinical context. A case presentation is followed by a description of diagnostic and management challenges, a review of the relevant literature, and a summary of the authors' suggested management approaches. The goal of this series is to help readers better understand how to apply the results of key studies, including those published in Journal of Clinical Oncology, to patients seen in their own clinical practice. A 14-year-old African American female presented with fatigue, easy bruising, and fever. On examination, she had scattered bruising, lymphadenopathy, and hepatosplenomegaly. Laboratory evaluation revealed pancytopenia with peripheral blasts, and acute myeloid leukemia (AML; French-American-British M2, t[8;21][q22;q22.1]) was diagnosed on bone marrow biopsy. A baseline echocardiogram revealed normal left ventricular (LV) systolic function (ejection fraction [EF], 60%; shortening fraction [SF], 32%), and conventional chemotherapy was initiated that consisted of two cycles of remission induction (cytarabine, etoposide, and daunorubicin [50 mg/m2 × 3 days per cycle]) followed by intensification 1 (high-dose cytarabine and etoposide), intensification 2 (high-dose cytarabine and mitoxantrone [12 mg/m2/dose daily; four total doses]), and intensification 3 (high-dose cytarabine and l-asparaginase). Of note, an echocardiogram was not repeated before the start of intensification 1. During intensification 1, the patient developed Streptococcus viridans sepsis, which required 4 days in the intensive care unit with antimicrobial and inotropic support. Repeat echocardiogram after recovery from the sepsis episode demonstrated low-normal LV systolic function (EF, 53%; SF, 27%), and she subsequently began intensification 2. On day 3 of intensification 2, the patient developed afebrile tachypnea, tachycardia, and an increasing oxygen requirement. Chest x-ray revealed cardiomegaly and pulmonary vascular congestion. Cardiac troponins were normal, whereas N-terminal pro B-type natriuretic peptide was 10 times the upper limit of normal. Repeat echocardiogram showed an enlarged LV with moderate to severely depressed LV function (EF, 28%; SF, 14%). Day 4 mitoxantrone was omitted and a cardiology consult obtained.

来源:J Clin Oncol,查看原文。版权归原作者所有。

引用

  1. Armenian SH, Ehrhardt MJ. Optimizing Cardiovascular Care in Children With Acute Myeloid Leukemia to Improve Cancer-Related Outcomes. J Clin Oncol. 2018. PMID: 30422740. doi:10.1200/JCO.18.01421

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。